Literature DB >> 24291059

Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies.

Federica Braga1, Mauro Panteghini2.   

Abstract

To be accurate and equivalent, laboratory results should be traceable to higher-order references. Furthermore, their analytical performance should fulfill acceptable measurement uncertainty criteria defined to fit the intended clinical use. With this aim, In Vitro Diagnostics (IVD) manufacturers should define a calibration hierarchy to assign traceable values to their system calibrators and to fulfill during this process uncertainty limits for calibrators, which should represent a proportion of the uncertainty budget allowed for laboratory results. It is important that end-users may know and verify how manufacturers have implemented the traceability of their calibrators and estimated the corresponding uncertainty. However, full information about traceability and combined uncertainty of calibrators is currently not available. Important tools for IVD traceability surveillance are the verification by laboratories of the consistency of declared performance during daily operations performed in accordance with the manufacturer's instructions and the organization of appropriately structured External Quality Assessment (EQA) programs. The former activity should be accomplished by analyzing system control materials and confirming that current measurements are in the manufacturer's established control range. With regard to EQA, it is mandatory that target values for materials are assigned with reference procedures by accredited laboratories, that materials are commutable and that a clinically allowable inaccuracy for participant's results is defined.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analytical goals; Blood glucose; Standardization; Uncertainty

Mesh:

Substances:

Year:  2013        PMID: 24291059     DOI: 10.1016/j.cca.2013.11.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  Standardization in laboratory medicine: Adoption of common reference intervals to the Croatian population.

Authors:  Zlata Flegar-Meštrić; Sonja Perkov; Andrea Radeljak
Journal:  World J Methodol       Date:  2016-03-26

2.  Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.

Authors:  Andrew N Hoofnagle; Jeffrey R Whiteaker; Steven A Carr; Eric Kuhn; Tao Liu; Sam A Massoni; Stefani N Thomas; R Reid Townsend; Lisa J Zimmerman; Emily Boja; Jing Chen; Daniel L Crimmins; Sherri R Davies; Yuqian Gao; Tara R Hiltke; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Matthew R Meyer; Wei-Jun Qian; Regine M Schoenherr; Mitchell G Scott; Tujin Shi; Gordon R Whiteley; John A Wrobel; Chaochao Wu; Brad L Ackermann; Ruedi Aebersold; David R Barnidge; David M Bunk; Nigel Clarke; Jordan B Fishman; Russ P Grant; Ulrike Kusebauch; Mark M Kushnir; Mark S Lowenthal; Robert L Moritz; Hendrik Neubert; Scott D Patterson; Alan L Rockwood; John Rogers; Ravinder J Singh; Jennifer E Van Eyk; Steven H Wong; Shucha Zhang; Daniel W Chan; Xian Chen; Matthew J Ellis; Daniel C Liebler; Karin D Rodland; Henry Rodriguez; Richard D Smith; Zhen Zhang; Hui Zhang; Amanda G Paulovich
Journal:  Clin Chem       Date:  2016-01       Impact factor: 8.327

Review 3.  Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned.

Authors:  Randie R Little; Robert I Wielgosz; Ralf Josephs; Tomoya Kinumi; Akiko Takatsu; Hongmei Li; Daniel Stein; Chris Burns
Journal:  Clin Chem       Date:  2017-06-23       Impact factor: 8.327

4.  EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing.

Authors:  Qing Tong; Shunli Zhang; Chang Zuo
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

Review 5.  Role and Responsibilities of Laboratory Medicine Specialists in the Verification OF Metrological Traceability of in vitro Medical Diagnostics.

Authors:  Federica Braga; Ilenia Infusino; Mauro Panteghini
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

Review 6.  The role of EQA in harmonization in laboratory medicine - a global effort.

Authors:  Graham R D Jones
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

Review 7.  Biological variation: Understanding why it is so important?

Authors:  Tony Badrick
Journal:  Pract Lab Med       Date:  2021-01-04

8.  Harmonization of Clinical Laboratory Test Results: The Role of the IVD Industry.

Authors:  Dave Armbruster; James Donnelly
Journal:  EJIFCC       Date:  2016-02-09

9.  Standardization in laboratory medicine: Two years' experience from category 1 EQA programs in Spain.

Authors:  Carmen Ricós; Carmen Perich; Beatriz Boned; Elisabet González-Lao; Jorge Diaz-Garzón; Montserrat Ventura; Sandra Bullich; Zoraida Corte; Joana Minchinela; Fernando Marques; Margarita Simón; Virtudes Alvarez; José-Vicente García-Lario; Pilar Fernández-Fernández; Pilar Fernández-Calle
Journal:  Biochem Med (Zagreb)       Date:  2018-12-15       Impact factor: 2.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.